Regado Biosciences (RGDO) Posts Q1 Loss of $1.30/Share

Regado Biosciences (NASDAQ: RGDO) reported Q1 EPS of ($1.30), $0.68 worse than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Regado Biosciences (RGDO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c